TELA Bio (TELA) Accounts Payables (2018 - 2026)
TELA Bio's (TELA) quarterly Accounts Payables came in at $3.9 million in Q1 2026, down 2.7% year-on-year from $4.0 million in Q1 2025, and up 68.64% quarter-over-quarter from $2.3 million in Q4 2025.
TELA Bio (TELA) Accounts Payables (2018 - 2026) Analysis & Trends
TELA Bio's Accounts Payables history runs 9 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Accounts Payables fell 2.7% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $3.9 million, a 2.7% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, up 7.55% from the prior year.
- Accounts Payables advanced to $3.9 million in Q1 2026 per TELA's latest filing, from $2.3 million in the prior quarter.
- Across five years, Accounts Payables topped out at $5.7 million in Q1 2022 and bottomed at $1.5 million in Q4 2022.
- The 5-year median for Accounts Payables is $2.4 million (2025), against an average of $3.0 million.
- Biggest YoY gain for Accounts Payables was 490.98% in 2022; the steepest drop was 36.45% in 2022.
- Year by year, Accounts Payables stood at $1.5 million in 2022, then advanced by 8.67% to $1.7 million in 2023, then rose by 28.79% to $2.1 million in 2024, then increased by 7.55% to $2.3 million in 2025, then jumped by 68.64% to $3.9 million in 2026.
- Per Business Quant, the three latest TELA Accounts Payables figures stand at $3.9 million (Q1 2026), $2.3 million (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | 3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.89 Mn |
| Dec 31, 2025 | 2.31 Mn |
| Sep 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 2.48 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 3.36 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 3.09 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 5.22 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 4.86 Mn |
| Jun 30, 2022 | 2.25 Mn |
| Mar 31, 2022 | 5.70 Mn |
| Dec 31, 2021 | 2.41 Mn |
| Sep 30, 2021 | 2.33 Mn |
| Jun 30, 2021 | 1.28 Mn |